1431 Rectal Cancer Outcomes at a UK Tertiary Centre: A Five-Year Retrospective Audit
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.609 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von A Mann und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Rectal cancer management has evolved significantly over the years, with increasing use of minimally invasive techniques, neoadjuvant therapy, and non-operative management. Understanding local outcomes is essential for evaluating services, identifying areas for improvement, and ensuring alignment with national standards.
Aim
To review all rectal cancer cases managed at University Hospitals Coventry and Warwickshire (UHCW) over a five-year period (January 2020–June 2025) and evaluate operative outcomes, non-operative pathways, complication rates, and mortality.
Method
A retrospective audit was conducted analysing 419 patients diagnosed with rectal cancer. Data collected included demographics, operative approach, neoadjuvant therapy response, postoperative complications (Clavien–Dindo grade ≥III), mortality at 3 months and 1 year, and recurrence in operatively managed patients. Cases with incomplete documentation were excluded (n=100).
Results
Of the 419 cases, 214 underwent surgery with curative intent. The most common operation was low anterior resection (n=63), followed by AP resection (n=58), high anterior resection (n=38), and TAMIS (n=28). Minimally invasive approaches predominated, including 174 robotic and 28 TAMIS procedures. Postoperative Clavien–Dindo ≥III complications included anastomotic leak (n=2), bleeding (n=1), collections (n=5), iatrogenic perforation (n=1), and stoma complications (n=1). Mortality was 1.40% at 3 months and 2.34% at 1 year. The recurrence rate among operatively managed patients was 10.75%. A total of 88 patients were managed non-operatively, with 16 achieving a complete response to chemoradiotherapy.
Conclusions
Rectal cancer outcomes at UHCW demonstrate high utilisation of minimally invasive surgery and low perioperative mortality. This audit highlights strong curative outcomes and supports continued development of robotic and organ-preserving strategies.
Zitieren
APA
Mann, A., Farrugia, A., Rajasivam, N., Azate, O., Bhura, S., Jotheeswaran, R., & Aslam, I. (2026). 1431 Rectal Cancer Outcomes at a UK Tertiary Centre: A Five-Year Retrospective Audit. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.609
Vancouver
Mann A, Farrugia A, Rajasivam N, Azate O, Bhura S, Jotheeswaran R, et al. 1431 Rectal Cancer Outcomes at a UK Tertiary Centre: A Five-Year Retrospective Audit. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.609
BibTeX
@article{Mann2026,
author = {Mann, A and Farrugia, A and Rajasivam, N and Azate, O and Bhura, S and Jotheeswaran, R and Aslam, I},
title = {1431 Rectal Cancer Outcomes at a UK Tertiary Centre: A Five-Year Retrospective Audit},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.609}
}
EUVIMED